Ligand validation:4TNJ

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 4TNJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TNJ_SQD_a_415	14%	34%	0.286	0.852	0.97	1.74	4	10	0	0	94%	0.9444
4TNJ_SQD_A_414	7%	37%	0.403	0.852	0.96	1.57	5	9	0	0	100%	1
4TNJ_SQD_b_602	4%	32%	0.382	0.795	1.02	1.79	4	10	0	0	87%	0.8704
4TNJ_SQD_D_403	4%	32%	0.414	0.818	1.04	1.78	3	10	0	0	80%	0.7963
4TNJ_SQD_A_413	3%	34%	0.368	0.73	0.97	1.72	4	10	0	0	94%	0.9444
4TNJ_SQD_B_626	2%	32%	0.464	0.788	1.02	1.77	4	10	0	0	87%	0.8704
4TNJ_SQD_f_103	2%	35%	0.519	0.841	1.04	1.63	4	11	0	0	83%	0.8333
4TNJ_SQD_a_401	2%	37%	0.582	0.837	0.96	1.56	4	9	0	0	100%	1
4TNJ_SQD_F_102	0%	34%	0.687	0.787	1.04	1.64	5	10	0	0	83%	0.8333
4TNJ_SQD_d_402	0%	31%	0.831	0.753	1.05	1.79	3	10	0	0	80%	0.7963
5V2C_SQD_a_413	94%	24%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	77%	23%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	32%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	75%	33%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	75%	32%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	33%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.